A Multicenter, Prospective Study of C2-Monitored Cyclosporine Microemulsion in a U.S. Population of De Novo Renal Transplant Recipients
Flavio Vincenti(University of California, San Francisco), Ralph Barbeito(Emory University), Ernesto P. Molmenti, John J. Curtis(University of Alabama at Birmingham), Enver Akalin(Brigham and Women's Hospital), Stanley C. Jordan(Cedars-Sinai Medical Center), Johann Jonsson(University of Alabama), Fuad S. Shihab(University of Utah), You-Min Wu(University of Iowa), Stephen M. Katz(Texas Medical Center), Robert M. Esterl(The University of Texas at San Antonio Health Science Center), Robert Mendez(Mendez National Institute of Transplantation), Jimmy A. Light(MedStar Washington Hospital Center), Kristene Gugliuzza(The University of Texas Medical Branch at Galveston), Thomas C. Pearson(Emory Healthcare)
Cited by 14
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714